[Treatment of atrial fibrillation in heart failure]. 2009

Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
Service de Cardiologie A et Rythmologie, Hôpital Européen Georges Pompidou, Université Paris 5, Paris, France. jean-yves.le-heuzey@egp.aphp.fr

Treatment of patients with both atrial fibrillation and heart failure remains uneasy. In theory maintenance of sinus rhythm is desirable but the only pharmacological intervention able to do it safely is amiodarone. A trial of strategy randomisation, restoration of sinus rhythm or slowing of atrial fibrillation, has been done in patients with both atrial fibrillation and heart failure. This trial, named AF-CHF has shown neutral results, the 2 strategies, rhythm control or simple rate control were similar in terms of mortality. Dronedarone is an innovative drug bringing new possibilities in the treatment of atrial fibrillation but it is contra-indicated in case of severe heart failure. Another possible approach is that of non pharmacological techniques. Sinus rhythm maintenance may be obtained by pulmonary vein isolation. The other possibility is the ablation of atrio-ventricular node with implantation of a pacemaker, technique which is reserved to selected patients.

UI MeSH Term Description Entries
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations

Related Publications

Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
September 2012, The Medical clinics of North America,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
June 2002, Herz,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
September 1999, The New England journal of medicine,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
December 2012, Current heart failure reports,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
March 2024, Journal of cardiovascular electrophysiology,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
September 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
April 2010, Recenti progressi in medicina,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
January 2009, Congestive heart failure (Greenwich, Conn.),
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
January 2008, Journal of atrial fibrillation,
Jean-Yves Le Heuzey, and Eloi Marijon, and Akli Otmani, and Antoine Lepillier, and Xavier Waintraub, and Thomas Lavergne, and Maurice Pornin
December 2020, AACN advanced critical care,
Copied contents to your clipboard!